Sun Pharmaceutical Industries Ltd Walk-in Interview .Sun Pharmaceutical Industries Ltd Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue.. Vacancy details: Department : Trainee Sales Executive (Medical Representative) – PAN INDIA Experience: 0 – 2 years Qualification: B.Pharma. / B.Sc. …
Aurobindo Pharma Limited Walk-in Interview.Aurobindo Pharma Limited Notification full details below. Interested and eligible candidates can attend Interview on scheduled time and venue. Vacancy details: Department – Production (Injectable)/QA Qualification – M. Pharmacy / B. Pharmacy / M. Sc /B Sc / Diploma / ITI Designation – Sr. Executive …
Biocon Biologics Walk-in Interview 2025.Biocon Biologics Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue.. Vacancy details: Experience: Freshers Qualification: B.Pharm, MSc (Chemistry, Biotechnology, Life science, Microbiology), BSc, B.Tech (Mechanical) Important Details : Location: Bangalore Selection Process: The selection will …
Cipla Limited Walk-in Interview 2025.Cipla Limited Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue.. Vacancy details: Department: Junior Team Member – QC/Junior Team Member – QA/Microbiology Experience: 2 years of experience Qualification: M.Sc. / B. Pharma/Bsc Important Details : …
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Sanofi presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-λ2 monoclonal antibody targeting TL1A, for the treatment of moderate-to-severe ulcerative colitis (UC) and Crohn’s disease (CD). The double-blinded, 14-week, …
Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd. announced that YESINTEK (ustekinumab-kfce) is now available to patients in the United States, and is one of the first Stelara (ustekinumab) biosimilar market entrants in the country. YESINTEK is approved …
Zydus, a leading, discovery-based, global pharmaceutical company is ready to launch the season’s first India’s Flu protection as per WHO recommended composition of quadrivalent influenza virus vaccines for use in the 2025 southern hemisphere. The company’s Quadrivalent Inactivated Influenza vaccine VaxiFlu-4 will offer protection against A/Victoria/4897/2022 …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
